Literature DB >> 25275926

Lung Angiogenesis Requires CD4(+) Forkhead Homeobox Protein-3(+) Regulatory T Cells.

Franco R D'Alessio1, Qiong Zhong, John Jenkins, Aigul Moldobaeva, Elizabeth M Wagner.   

Abstract

Angiogenesis in ischemic organs is modulated by immune cells. Systemic neovascularization of the ischemic lung requires macrophages, with chemokines playing a central role in new vessel growth. Because regulatory T (Treg) cells modulate tumor-induced neovascularization, we questioned whether this CD4(+) lymphocyte subset impacts blood vessel growth during ischemia. In a model of left lung ischemia, an increase in CD4(+) CD25(+) forkhead homeobox protein-3 (Foxp3)(+) cells was observed 3-5 days after the onset of ischemia in wild-type C57Bl/6 mice. Using transgenic mice where Foxp3(+) Treg cells can be depleted with diphtheria toxin (DT; Foxp3(DTR)), we unexpectedly found that Foxp3(+) Treg depletion led to markedly reduced lung angiogenesis (90% reduction from Foxp3(gfp) controls). Adoptive transfer studies using CD4(+) CD25(+) splenocytes from congenic CD45.1 mice into Foxp3(+) Treg-depleted mice showed an almost complete recovery of the angiogenic phenotype (80% of Foxp3(gfp) controls). A survey of lung gene expression of angiogenic (lipopolysaccharide-induced CXC chemokine [LIX], IL-6, IL-17) and angiostatic (IFN-γ, transforming growth factor-β, IL-10) cytokines showed Treg-dependent differences only in LIX (CXCL5) and IL-6. Protein confirmation demonstrated a significant reduction in LIX in Treg-deficient mice compared with controls 5 days after the onset of ischemia. Phenotyping other inflammatory cells in the lung by multicolor flow cytometry demonstrated a significantly reduced number of macrophages (major histocombatibility complex class II [MHCII](int), CD11C(+)) in Treg-deficient lungs compared with Treg-sufficient lungs. Treg cells are essential for maximal systemic angiogenesis after pulmonary ischemia. One likely mechanism responsible for the decrease in angiogenesis in Treg-depleted mice was the decline in the essential CXC chemokine, LIX.

Entities:  

Keywords:  CXC chemokines; angiogenesis; ischemia; regulatory T cells

Mesh:

Substances:

Year:  2015        PMID: 25275926      PMCID: PMC4491140          DOI: 10.1165/rcmb.2014-0278OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  32 in total

Review 1.  Angiogenesis in paediatric airway disease.

Authors:  John W Wilson; Colin F Robertson
Journal:  Paediatr Respir Rev       Date:  2002-09       Impact factor: 2.726

2.  Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species.

Authors:  Marina D Kraaij; Nigel D L Savage; Sandra W van der Kooij; Karin Koekkoek; Jun Wang; J Merlijn van den Berg; Tom H M Ottenhoff; Taco W Kuijpers; Rikard Holmdahl; Cees van Kooten; Kyra A Gelderman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-22       Impact factor: 11.205

3.  Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress.

Authors:  Jianguo Du; Jing Luan; Hua Liu; Thomas O Daniel; Stephen Peiper; Theresa S Chen; Yingchun Yu; Linda W Horton; Lillian B Nanney; Robert M Strieter; Ann Richmond
Journal:  J Leukoc Biol       Date:  2002-01       Impact factor: 4.962

4.  Angiogenesis in the mouse lung.

Authors:  W Mitzner; W Lee; D Georgakopoulos; E Wagner
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

5.  Hypoxia does neither stimulate pulmonary artery endothelial cell proliferation in mice and rats with pulmonary hypertension and vascular remodeling nor in human pulmonary artery endothelial cells.

Authors:  Lunyin Yu; Charles A Hales
Journal:  J Vasc Res       Date:  2011-06-17       Impact factor: 1.934

6.  CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Erin E West; Matthew H Willett; Martin F Britos; Matthew R Pipeling; Roy G Brower; Rubin M Tuder; John F McDyer; Landon S King
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

Review 7.  A review of gene expression in porcine endometrial lymphocytes, endothelium and trophoblast during pregnancy success and failure.

Authors:  Chandrakant Tayade; Yuan Fang; Barbara Anne Croy
Journal:  J Reprod Dev       Date:  2007-06       Impact factor: 2.214

8.  Effects of ischemia on lung macrophages.

Authors:  Aigul Moldobaeva; Nico van Rooijen; Elizabeth M Wagner
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

9.  Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation.

Authors:  Franziska Boehm; Maria Martin; Rebecca Kesselring; Gabriela Schiechl; Edward K Geissler; Hans-Jürgen Schlitt; Stefan Fichtner-Feigl
Journal:  BMC Gastroenterol       Date:  2012-07-31       Impact factor: 3.067

10.  Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis.

Authors:  Greg M Delgoffe; Seng-Ryong Woo; Meghan E Turnis; David M Gravano; Cliff Guy; Abigail E Overacre; Matthew L Bettini; Peter Vogel; David Finkelstein; Jody Bonnevier; Creg J Workman; Dario A A Vignali
Journal:  Nature       Date:  2013-08-04       Impact factor: 49.962

View more
  12 in total

1.  Delayed Akt suppression in the lipopolysaccharide-induced acute lung injury promotes resolution that is associated with enhanced effector regulatory T cells.

Authors:  Sandeep Artham; Arti Verma; Abdulrahman Alwhaibi; Mir S Adil; Santhakumar Manicassamy; David H Munn; Payaningal R Somanath
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-02-19       Impact factor: 5.464

2.  T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.

Authors:  Mohammad Afzal Khan
Journal:  Mol Med       Date:  2016-11-22       Impact factor: 6.354

Review 3.  Reparative T lymphocytes in organ injury.

Authors:  Franco R D'Alessio; Johanna T Kurzhagen; Hamid Rabb
Journal:  J Clin Invest       Date:  2019-07-01       Impact factor: 14.808

4.  A Review of the CD4+ T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population.

Authors:  Ravi S Misra
Journal:  EC Microbiol       Date:  2014

5.  Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis.

Authors:  Anandharajan Rathinasabapathy; Erin Bruce; Andrew Espejo; Alana Horowitz; Dhivya R Sudhan; Anand Nair; Dominic Guzzo; Joseph Francis; Mohan K Raizada; Vinayak Shenoy; Michael J Katovich
Journal:  Br J Pharmacol       Date:  2016-08-26       Impact factor: 8.739

6.  Effector T Cells and Ischemia-Induced Systemic Angiogenesis in the Lung.

Authors:  Qiong Zhong; John Jenkins; Aigul Moldobaeva; Franco D'Alessio; Elizabeth M Wagner
Journal:  Am J Respir Cell Mol Biol       Date:  2016-03       Impact factor: 6.914

Review 7.  Regulatory T Cells in Angiogenesis.

Authors:  Zala Lužnik; Sonia Anchouche; Reza Dana; Jia Yin
Journal:  J Immunol       Date:  2020-11-15       Impact factor: 5.426

Review 8.  Cellular Therapies in Systemic Sclerosis: Recent Progress.

Authors:  Femke C C van Rhijn-Brouwer; Hendrik Gremmels; Joost O Fledderus; Timothy R D Radstake; Marianne C Verhaar; Jacob M van Laar
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

9.  A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment.

Authors:  Mingyue Li; Shugang Xing; Haiying Zhang; Siqi Shang; Xiangxiang Li; Bo Ren; Gaiyun Li; Xiaona Chang; Yilei Li; Wei Li
Journal:  Oncol Rep       Date:  2016-01-05       Impact factor: 3.906

10.  IL-10 Mediated Immunomodulation Limits Subepithelial Fibrosis and Repairs Airway Epithelium in Rejecting Airway Allografts.

Authors:  Mohammad Afzal Khan; Ghazi Abdulmalik Ashoor; Talal Shamma; Fatimah Alanazi; Abdullah Altuhami; Shadab Kazmi; Hala Abdalrahman Ahmed; Abdullah Mohammed Assiri; Dieter Clemens Broering
Journal:  Cells       Date:  2021-05-19       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.